This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Oct;22(10):1342-1343.

doi: 10.1016/S1470-2045(21)00518-0. Epub 2021 Sep 21.

Access to and affordability of cancer medicines: time to focus on the last mile

Bhawna Sirohi¹, Aju Mathew²

Affiliations

Affiliations

¹ Apollo Proton Cancer Centre, Chennai 600041, India. Electronic address: bhawna.sirohi13@gmail.com.
² Malankara Orthodox Syrian Church Medical College, Kerala, India; Department of Medicine, University of Kentucky, Lexington, KY, USA.

PMID: 34560007
DOI: 10.1016/S1470-2045(21)00518-0

Comment

Access to and affordability of cancer medicines: time to focus on the last mile

Bhawna Sirohi et al. Lancet Oncol. 2021 Oct.

. 2021 Oct;22(10):1342-1343.

doi: 10.1016/S1470-2045(21)00518-0. Epub 2021 Sep 21.

Authors

Bhawna Sirohi¹, Aju Mathew²

Affiliations

¹ Apollo Proton Cancer Centre, Chennai 600041, India. Electronic address: bhawna.sirohi13@gmail.com.
² Malankara Orthodox Syrian Church Medical College, Kerala, India; Department of Medicine, University of Kentucky, Lexington, KY, USA.

PMID: 34560007
DOI: 10.1016/S1470-2045(21)00518-0

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey.
Fundytus A, Sengar M, Lombe D, Hopman W, Jalink M, Gyawali B, Trapani D, Roitberg F, De Vries EGE, Moja L, Ilbawi A, Sullivan R, Booth CM. Fundytus A, et al. Lancet Oncol. 2021 Oct;22(10):1367-1377. doi: 10.1016/S1470-2045(21)00463-0. Epub 2021 Sep 21. Lancet Oncol. 2021. PMID: 34560006 Free PMC article.

Similar articles

Availability, Price and Affordability of Anticancer Medicines: Evidence from Two Cross-Sectional Surveys in the Jiangsu Province, China.
Zhu Y, Wang Y, Sun X, Li X. Zhu Y, et al. Int J Environ Res Public Health. 2019 Oct 3;16(19):3728. doi: 10.3390/ijerph16193728. Int J Environ Res Public Health. 2019. PMID: 31623326 Free PMC article.
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.
Moye-Holz D, Ewen M, Dreser A, Bautista-Arredondo S, Soria-Saucedo R, van Dijk JP, Reijneveld SA, Hogerzeil HV. Moye-Holz D, et al. BMC Health Serv Res. 2020 May 14;20(1):424. doi: 10.1186/s12913-020-05167-9. BMC Health Serv Res. 2020. PMID: 32410676 Free PMC article.
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ, Datta BK, Kostova D, Joseph KT, Asma S, Richter P, Jaffe MG, Kishore SP. Husain MJ, et al. J Am Heart Assoc. 2020 May 5;9(9):e015302. doi: 10.1161/JAHA.119.015302. Epub 2020 Apr 25. J Am Heart Assoc. 2020. PMID: 32338557 Free PMC article.
A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications.
Baxi SM, Beall R, Yang J, Mackey TK. Baxi SM, et al. Global Health. 2019 Sep 18;15(1):57. doi: 10.1186/s12992-019-0497-3. Global Health. 2019. PMID: 31533850 Free PMC article. Review.
Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.
Beran D, Ewen M, Lipska K, Hirsch IB, Yudkin JS. Beran D, et al. Curr Diab Rep. 2018 Jun 16;18(8):48. doi: 10.1007/s11892-018-1019-z. Curr Diab Rep. 2018. PMID: 29907884 Review.

See all similar articles

Cited by

Acute graft-versus-host disease.
Malard F, Holler E, Sandmaier BM, Huang H, Mohty M. Malard F, et al. Nat Rev Dis Primers. 2023 Jun 8;9(1):27. doi: 10.1038/s41572-023-00438-1. Nat Rev Dis Primers. 2023. PMID: 37291149 Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information